Our top pick for
Building a portfolio
Investors Title Company is an insurance-specialty business based in the US. Investors Title Company shares (ITIC) are listed on the NASDAQ and all prices are listed in US Dollars. Investors Title Company employs 396 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$95.56 - $178.31|
|50-day moving average||$167.73|
|200-day moving average||$158.62|
|Wall St. target price||$39.00|
|Dividend yield||$1.76 (1.02%)|
|Earnings per share (TTM)||$20.80|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Investors Title Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Investors Title Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Investors Title Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Investors Title Company shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Investors Title Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $51.9 million.
The EBITDA is a measure of a Investors Title Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$236.4 million|
|Operating margin TTM||21%|
|Gross profit TTM||$124.4 million|
|Return on assets TTM||11.35%|
|Return on equity TTM||20.12%|
|Market capitalisation||$334.3 million|
TTM: trailing 12 months
There are currently 14,395 Investors Title Company shares held short by investors – that's known as Investors Title Company's "short interest". This figure is 1.6% down from 14,625 last month.
There are a few different ways that this level of interest in shorting Investors Title Company shares can be evaluated.
Investors Title Company's "short interest ratio" (SIR) is the quantity of Investors Title Company shares currently shorted divided by the average quantity of Investors Title Company shares traded daily (recently around 2919.878296146). Investors Title Company's SIR currently stands at 4.93. In other words for every 100,000 Investors Title Company shares traded daily on the market, roughly 4930 shares are currently held short.
However Investors Title Company's short interest can also be evaluated against the total number of Investors Title Company shares, or, against the total number of tradable Investors Title Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Investors Title Company's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Investors Title Company shares in existence, roughly 10 shares are currently held short) or 0.0121% of the tradable shares (for every 100,000 tradable Investors Title Company shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Investors Title Company.
Find out more about how you can short Investors Title Company stock.
Dividend payout ratio: 50.38% of net profits
Recently Investors Title Company has paid out, on average, around 50.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Investors Title Company shareholders could enjoy a 1.02% return on their shares, in the form of dividend payments. In Investors Title Company's case, that would currently equate to about $1.76 per share.
Investors Title Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Investors Title Company's most recent dividend payout was on 29 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 21 March 2021 (the "ex-dividend date").
Investors Title Company's shares were split on a 2:1 basis on 15 September 1987. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Investors Title Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Investors Title Company shares which in turn could have impacted Investors Title Company's share price.
Over the last 12 months, Investors Title Company's shares have ranged in value from as little as $95.5639 up to $178.3122. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Investors Title Company's is 0.85. This would suggest that Investors Title Company's shares are less volatile than average (for this exchange).
Investors Title Company, through its subsidiaries, engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies. It also provides services in connection with tax-deferred exchanges of like-kind property; acts as a qualified intermediary in tax-deferred exchanges of property; coordinates the exchange aspects of the real estate transaction, such as drafting standard exchange documents, holding the exchange funds between the sale of the old property and the purchase of the new property, and accepting the formal identification of the replacement property. In addition, it serves as an exchange accommodation titleholder for accomplishing reverse exchanges when the taxpayers decide to acquire replacement property before selling the relinquished property. Further, the company offers investment management and trust services to individuals, companies, banks, and trusts; and consulting and management services to clients to start and operate a title insurance agency. It issues title insurance policies primarily through approved attorneys from underwriting offices, as well as through independent issuing agents in 21 states and the District of Columbia, primarily in the eastern half of the United States. The company was founded in 1972 and is headquartered in Chapel Hill, North Carolina.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.